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Abstract
Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and
activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of
the mitochondria-adapter MAVS. Here, we have investigated the early events of IFN induction upon HCV infection, using the
cell-cultured HCV JFH1 strain and the new HCV-permissive hepatoma-derived Huh7.25.CD81 cell subclone. These cells
depend on ectopic expression of the RIG-I ubiquitinating enzyme TRIM25 to induce IFN through the RIG-I/MAVS pathway.
We observed induction of IFN during the first 12 hrs of HCV infection, after which a decline occurred which was more
abrupt at the protein than at the RNA level, revealing a novel HCV-mediated control of IFN induction at the level of
translation. The cellular protein kinase PKR is an important regulator of translation, through the phosphorylation of its
substrate the eIF2a initiation factor. A comparison of the expression of luciferase placed under the control of an eIF2a-
dependent (IRES
EMCV) or independent (IRES
HCV) RNA showed a specific HCV-mediated inhibition of eIF2a-dependent
translation. We demonstrated that HCV infection triggers the phosphorylation of both PKR and eIF2a at 12 and 15 hrs post-
infection. PKR silencing, as well as treatment with PKR pharmacological inhibitors, restored IFN induction in JFH1-infected
cells, at least until 18 hrs post-infection, at which time a decrease in IFN expression could be attributed to NS3/4A-mediated
MAVS cleavage. Importantly, both PKR silencing and PKR inhibitors led to inhibition of HCV yields in cells that express
functional RIG-I/MAVS. In conclusion, here we provide the first evidence that HCV uses PKR to restrain its ability to induce
IFN through the RIG-I/MAVS pathway. This opens up new possibilities to assay PKR chemical inhibitors for their potential to
boost innate immunity in HCV infection.
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Introduction
In response to invasion with bacterial or viral pathogens, cells
are able to mount an immediate immune response through their
ability to use specialized cellular molecules, referred to as pattern
recognition receptors or PRRs, to detect unusual DNA, ssRNA or
dsRNA structures. Among these PRRs, are the CARD-containing
DexD/H RNA helicases RIG-I and MDA5, which are activated
upon binding either to both 59-triphosphate ssRNA and short
double-stranded RNA structures (RIG-I) or to long dsRNA and
higher-ordered RNA structures (MDA5) [1]. Once activated, these
RNA helicases interact with the mitochondria-bound MAVS
adapter protein [2]. In the case of RIG-I, the interaction with
MAVS requires ubiquitination of the CARD domain of RIG-I by
the TRIM25 ubiquitin ligase [3]. Subsequently, MAVS is able to
recruit the IKK complex and the TBK1/IKKe kinases that are
responsible for the activation of the NF-kB and IRF3/IRF7
transcription factors, respectively. This leads to induction of the
interferons and pro-inflammatory cytokines that are involved in
the innate immune response [4].
Hepatitis C virus (HCV) (Hepacivirus genus within the Flaviviridae
family) is one of the RIG-I-activating viruses [4], because of its
59ppp-structured RNA, 39-structured genomic RNA and replica-
tive RNA duplexes [5]. In particular, its 39-end poly-U/UC motif
has been shown to function in conjunction with the 59ppp as the
HCV structure that activates RIG-I [6].
In contrast to other RIG-I activating viruses such as Sendai
virus, influenza, or vesicular stomatitis virus [1], HCV is a poor
inducer of IFN and pro-inflammatory cytokines in cell culture
systems. One reason for this is that the HCV NS3/4A protease
cleaves MAVS, resulting in a rapid disruption of the function of
MAVS and in abrogation of the IFN induction pathway [2].
However, data presented in some studies performed using Huh7
hepatoma cells infected with cell-culture generated JFH1 virus
showed that the IFN pathway was poorly activated even before full
cleavage of MAVS, since only limited nuclear translocation of
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10575IRF3 could be detected [7,8]. Similarly, in another study, infection
of Huh7 cells with JFH1 did not lead to any IFN induction,
whereas the cells responded well to transfection by synthetic
dsRNA poly(I)-poly(C) [9]. Thus, the early events leading to IFN
induction after RIG-I activation by HCV are still not well-
characterized.
Here, we have re-addressed the question as to whether HCV
infection can activate RIG-I/MAVS before cleavage of MAVS by
the NS3/4A protease, by performing kinetics of infection with
JFH1 in the newly described JFH1-permissive Huh7.25/CD81
cells, which were manipulated to present a functional RIG-I/
MAVS pathway. Our results show that HCV infection can
stimulate the IFN induction pathway up to 12 hrs post-infection,
whereas detection of MAVS cleavage begins at 18 hrs post-
infection and is maximal at 24 hrs. Importantly, our data reveal
that 12 hrs post-infection, HCV promotes a rapid inhibition of
IFN induction at the level of translation, indicating a new
mechanism of regulation. We demonstrated that this regulation
was linked to activation of the dsRNA-activated eIF2a kinase PKR
[10]. Altogether, our results show that HCV uses PKR to control
the translation of newly transcribed IFN mRNAs before sufficient
NS3/4A protein can be synthesized to efficiently restrain
transcription of IFN.
Results
Ectopic expression of TRIM25 allows IFN induction in
JFH1 permissive Huh7.25/CD81 cells to be studied
There is at present no satisfactory cell culture system that is both
permissive for HCV and presents an intact RIG-I pathway. For
instance, the Huh7.5 cells, which were cloned from the hepatoma
Huh7 cells for their efficacy to support HCV replication [11], are
unable to stimulate IFN induction because of a T55I substitution
in the first CARD domain of RIG-I that prevents the association
of RIG-I with MAVS [5]. Recently, another Huh7 subclone that
could efficiently replicate the JFH1 subgenomic replicon (clone
Huh7.25) was stably transfected with the essential HCV CD81
receptor, to generate Huh7.25/CD81 cells that are highly
permissive to infection by JFH1[12]. We compared the ability of
Huh7.25/CD81, Huh7.5 and Huh7 cells to activate the IFN
inducing pathway after transfection with an IFNb-luciferase
reporter and infection with Sendai virus (Figure 1). The results
showed that Huh7.25/CD81 cells are defective in the IFN-
inducing pathway, similarly to Huh7.5 cells. In contrast, Huh7
cells can mount a robust IFN induction in response to infection
with Sendai virus. Interestingly, whereas ectopic expression of
MAVS in both Huh7.25/CD81 and Huh7.5 cells resulted in a
strong stimulation of IFNb-luciferase, ectopic expression of RIG-I
was not able to restore the IFN-inducing pathway in Huh7.25/
CD81 cells, in contrast to in Huh7.5 cells where it was able to do
so as expected. This indicated that the defect in Huh7.25/CD81
cells was upstream of MAVS and either at the level of RIG-I or
downstream of RIG-I. Since efficient activation of MAVS by RIG-
I has been shown to depend upon the ubiquitination of RIG-I by
the ubiquitin ligase TRIM25 [3], we assayed the effect of TRIM25
in Huh7.25/CD81 cells. Ectopic expression of TRIM25 in
Huh7.25/CD81 cells had no effect alone, but resulted in a strong
induction of IFN when the cells were infected with Sendai virus,
indicating that these cells present a defect in the RIG-I/MAVS
pathway at the level of TRIM25. Whatever the nature of this
Figure 1. Ectopic expression of TRIM25 restores IFN induction in Huh7.25.CD81 cells. Huh7, Huh7.5 and Huh7.25.CD81 cells were
transfected with the pGL2-IFNb-FLUC/pRL-TK-RLUC reporter plasmids alone or the in presence of plasmids expressing RIG-I (200 ng), TRIM25 (100 ng)
or MAVS (400 ng). 24 hrs post transfection, cells were mock-infected or infected with Sendaı ¨ virus (SeV) (40 HAU/ml). 24 hrs after infection, luciferase
activity was measured and F-luc was normalized against R-luc. IFN expression was expressed as fold induction over control cells that were simply
transfected with pGL2-IFNb-FLUC/pRL-TK-RLUC. Error bars represent the mean 6 S.D. for triplicates.
doi:10.1371/journal.pone.0010575.g001
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Huh7.25/CD81 cells as a model to examine the effect of HCV
infection on the IFN induction pathway.
HCV specifically stimulates the IFN induction pathway
during the first 12 hrs of infection, but inhibits it
thereafter
To estimate the time-frame required to study IFN induction
before its abrogation upon the action of NS3/4A, we first
established the kinetics of MAVS cleavage in the two HCV
permissive cell lines Huh7.25/CD81 and Huh7.5 following HCV
infection. MAVS cleavage can be detected by immunoblotting,
which shows a progressive diminution of the MAVS full-length
protein (540 aa) and the apparition of a MAVS cleavage product
(513 aa) [2]. In our experimental conditions, MAVS cleavage was
clearly detected in both cell types at 48 hrs after infection with
JFH1 (Figures 2A and B). Since ectopic expression of TRIM25 in
Huh7.25/CD81 cells will be needed in our subsequent experi-
ments designed to examine the effects of HCV on the IFN
induction pathway, we also established the kinetics of MAVS
cleavage in these cells after their transfection with a plasmid that
expresses HA-TRIM25. Under these conditions, MAVS cleavage
was clearly observed at 48 hrs (Figure 2C). In all cases, the viral
NS3 protease was detected as early as 18–24 hrs, and thereafter its
expression increased strongly with time, concomitantly with
MAVS cleavage.
Huh7.25/CD81 or Huh7.5 cells were transfected with an
IFNb-luciferase reporter plasmid in the presence of limited
amounts of TRIM25 or RIG-I, respectively, and infected with
HCV at an moi of 0.2 or with Sendai virus as control. In case of
HCV infection, analysis of luciferase activity or of the expression
of endogenous IFNb RNA and HCV RNA was performed in
parallel. The results show an increase in luciferase activity that
corresponds to an increase in the activation of the RIG/MAVS
pathway (Figure 3A,C bottom). This increase was detected as early
as 6 hrs after infection for Huh7.25/CD81 cells and 10.5 hrs for
Huh7.5 cells, with a maximum expression at 12 hrs for both cell
types. The data of the reporter assay were also confirmed at the
endogenous level when induction of endogenous IFNb RNA was
assessed by RTqPCR (Figure 3B,D). In both cases, the expression
Figure 2. Kinetics of MAVS cleavage in Huh7.25.CD81 cells after JFH1 infection. Huh7.5 cells and Huh7.25.CD81 cells were transfected with
an HA-TRIM25 expressing plasmid or with an empty plasmid. 24 hrs post-transfection, cells were mock-infected or infected with JFH1 (m.o.i=0.05) for
the indicated times and cell lysates were generated. Cell extracts (50 mg) were subjected to SDS-12.5% PAGE and blotted with anti-MAVS, anti-NS3,
anti-HA or anti-actin as indicated. The arrows indicate the position of full-length MAVS and MAVS cleaved in the presence of HCV NS3/4A.
doi:10.1371/journal.pone.0010575.g002
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continues to rise thereafter. These results indicate that HCV can
activate the RIG-I signalling pathway with concomitant IFN
induction within the first 12 hrs of infection.
Intriguingly, we observed that after 12 hrs of infection, there was a
considerable decline of luciferase activity in both cell types, whereas the
levels of endogenous IFNb RNA remained at a plateau level until
18 hrs, before decreasing at 24 hrs post-infection. The decrease in
luciferase expression between 12 and 18 hrs was surprising since NS3
was not fully expressed within this period of time (Figure 3A,C). In
contrast, a decrease in luciferase expression at 24 hrs was expected, due
to the massive proteolytic cleavage of MAVS by the HCV NS3/4A
protease (Figure 2). Inhibition of luciferase activity was shown to be
specific to HCV, as infection of both cell types with Sendai virus
resulted in a continuous increase of luciferase activity from the IFNb-
luc reporter plasmid (Figure 3A,C top). Altogether, our data indicate
that HCV can activate the IFN induction pathway within 12 hrs after
infection, but blocks it prior to the NS3/4A-mediated cleavage of
MAVS.
HCV activates the phosphorylation of PKR and of its
substrate eIF2a, as of 12 hrs post-infection
The results shown in Figure 3 suggested a control of IFN
expression by HCV at the protein level. In addition to this, an
analysis of the effect of infection on the activity of a different
luciferase reporter construct (TK-Renilla luciferase; Figure S1)
Figure 3. HCV induces IFN during the first 12 hrs of infection and inhibits it thereafter. Huh7.25.CD81 and Huh7.5 cells were transfected
with the pGL2-IFNb-FLUC/pRL-TK-RLUC reporter plasmids together with plasmids expressing HA-TRIM25 (Huh7.25.CD81; A and B) or RIG-I (Huh7.5; C
and D). 24 h post-transfection, the cells were infected with SeV (40 HAU/ml) or JFH1 (m.o.i=0.2). A and C: 24 hrs post-transfection, the cells were
infected with SeV (40 HAU/ml) or JFH1 (m.o.i=0.2). At the times indicated, cell lysates were prepared and analysed for IFN induction as described in
Materials and Methods. The graphs represent the levels of F-luc activity normalized to R-luc RNA expressed as IFN-b fold-induction over control cells
that were simply transfected with pGL2-IFNb-FLUC/pRL-TK-RLUC. Error bars represent the mean 6 S.D. for triplicates. In addition, cell lysates from
JFH1-infected cells were pooled and analysed for the presence of NS3 as a marker of HCV infection. B and D: 24 hrs post-transfection, Huh7.25.CD81
and Huh7.5 cells were infected with JFH1 (m.o.i=0.2). At the times indicated, cells were processed for RNA extraction and HCV or IFNb RNA were
quantified by qRT-PCR respectively, and normalized against RNA from GAPDH. Error bars represent the mean 6 S.D. for triplicates.
doi:10.1371/journal.pone.0010575.g003
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HCV and not with Sendaı ¨ virus, indicating that HCV could exert
a control on protein expression at the general translational level.
One possible candidate that could exert such a control is the
protein kinase PKR, which inhibits protein synthesis through
phosphorylation of the initiation factor eIF2a [13]. Activation of
the catalytic domain of PKR is mediated by a change in its
conformation due to the interaction of its N terminus with dsRNA
structures or with specific proteins [10]. The fact that IFN could
be induced during the first 12 hrs post-infection with JFH1 in
Huh7.25.CD81/TRIM25 or in Huh7.5/RIG-I cells was an
indication that HCV dsRNA structures had appeared in the
cytosol that activate RIG-I and that these structures may also
represent good candidates to activate PKR. We therefore
examined the state and dynamics of phosphorylation of PKR
and of its substrate eIF2a upon HCV infection, using Huh7.25/
CD81 cells, either as such or upon ectopic expression of TRIM25.
At different times post-infection, cell extracts were immunopre-
cipitated with antibodies directed against PKR or eIF2a, after
which the degree of PKR or eIF2a phosphorylation was examined
using anti-phospho PKR (residue Thr451) or anti-phospho eIF2a
(residue Ser51) antibodies and by performing quantification of the
p-PKR/PKR or the p-eIF2a/eIF2a ratio. The results clearly
showed peaks of PKR (Figure 4) and eIF2a (Figure 5) phosphor-
ylation as early as 12 and 15 hrs post-infection, followed by a
decrease of phosphorylation until 24 hrs and a second increase
until 72 hrs post-infection, the end-point of the experiment. The
presence of TRIM25 was not found to significantly affect PKR or
eIF2a phosphorylation, except for a less abrupt decline between15
and 24 hrs. Altogether, these results show that PKR and its
substrate eIF2a are activated in the early hours of HCV infection.
HCV infection triggers inhibition of protein translation
HCV belongs to the family of viruses with 59 IRES structures
that are translated after direct binding of ribosomes to the RNA in
the vicinity of the initiation codon. Interestingly, unlike most viral
Figure 4. HCV activates the phosphorylation of PKR at 12 and 15 hrs post infection. A and C: Huh7.25.CD81 cells, plated into 100 cm
2
plates, were transfected with the HA-TRIM25 expressing plasmid or with an empty plasmid. 24 hrs post-transfection, cells were infected with JFH1 at
an m.o.i of 0.2. At the indicated times post-infection, cell extracts (1 mg) were incubated with Mab 71/10 anti-PKR. In addition, cell extracts prepared
at time 0 or at 72 hrs p.i. were incubated with mouse IgG as a control of specificity. The immunoprecipitated complexes were run on two different
NuPAGE gels and blotted using Mab 71/10 or anti-phosphorylated PKR (PKR-P). The presence of PKR and PKR-P was revealed using the Odyssey
procedure. B and D: The bands corresponding to total PKR and their corresponding phosphorylated proteins were quantified using the Odyssey
software and expressed as the ratio PKR-P/PKR in the absence (B) or presence (D) of HA-TRIM25.
doi:10.1371/journal.pone.0010575.g004
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independent of eIF2a phosphorylation in situations of stress
[14,15]. To establish a correlation between the observed HCV-
mediated PKR and eIF2a phosphorylation, and a possible
inhibition of eIF2a-dependent translation by HCV, we next
compared the effects of HCV infection on the kinetics of
expression of a luciferase reporter placed under the control of
the IRES
HCV (insensitive to eIF2a phosphorylation) or under that
of the IRES
EMCV (sensitive to eIF2a phosphorylation). The
experiment was done in Huh7.25/CD81 cells transfected with a
TRIM25-expressing plasmid, to perform the analysis in conditions
leading to IFN induction. For each IRES-luc expressing plasmid,
we took care to choose concentrations of these plasmids that give
similar levels of RNA expression or luciferase activity (data not
shown and Figure 6). After transfection by the different plasmids,
the cells were infected with JFH1 and the levels of RNA or
luciferase expression followed over 24 hrs. The expression levels of
IRES
EMCV RNA and IRES
HCV RNA were found to increase
similarly with time post-infection (Figures 6A and C). In contrast,
there was a dramatic difference in the expression levels of
luciferase expressed from the IRES
EMCV compared to that
expressed from the IRES
HCV (Figures 6B and D). Expression of
luciferase from the IRES
EMCV was strongly inhibited at 12 hrs
post-infection with JFH1, after which time it was progressively
restored until at 24 hrs post-infection it approached its initial level.
In contrast, expression of luciferase from the HCV IRES was not
inhibited at any time after infection with JFH1. Rather, it steadily
increased with time post-infection. Similarly to the experiment
presented in Figure 3, concomitant analysis of luciferase activity
placed under a TK promoter revealed inhibition at 12 hrs post-
infection with HCV, regardless of the presence of IRES
EMCV or
IRES
HCV, again indicating that the inhibition effect is due to
HCV infection and occurs at a general level (Figure S2). These
results demonstrate that HCV infection triggers inhibition of
general translation, while translation from the IRES
HCV is
unaffected. Since inhibition of translation occurs at 12 hrs post-
infection, at a time when PKR and eIF2a are phosphorylated
(Figures 4 and 5), this shows a correlation between an HCV-
mediated inhibition of protein synthesis and PKR/eIF2a phos-
phorylation; a hallmark of eIF2a-dependent translation.
Depletion of PKR increases IFN induction
We next examined further the role of the ability of HCV to
activate PKR in the early events of infection, in relation to IFN
Figure 5. HCV activates the phosphorylation of eIF2a at 12 and 15 hrs post infection. The detection of eIF2a and eIF2a-P and the
quantification of the ratio eIF2a-P/eIF2a in the absence (A and B) or in the presence (C and D) of HA-TRIM25 was performed as described in the
legend to Figure 4.
doi:10.1371/journal.pone.0010575.g005
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siRNAs or siRNA directed against PKR, in conditions that allow
complete depletion of PKR (Figure 7B). They were then
transfected with TRIM25 in the presence of the IFNb-luciferase
reporter plasmid. Cells that express normal endogenous levels of
PKR presented an initial increase in IFNb-luciferase induction up
to 12–15 hrs in response to infection with JFH1 followed by a
sudden decline (Figure 7A), similarly to the results described in
Figure 3. In contrast, induction of IFNb-luciferase continued to
increase past 15 hrs post-infection in cells in which PKR
expression was silenced. In both cases, a decrease of IFN
expression at 24 hrs was correlated with strong NS3 expression
in the cytosol (Figure 7A). Concomitant analysis of the activity of
luciferase placed under a TK promoter revealed the same pattern
of inhibition of expression during HCV infection, which was
alleviated when PKR was silenced. This confirmed that HCV-
mediated inhibition at the general level occurs through PKR
(Figure S3). Therefore, these results demonstrate the role of PKR
activation in controlling IFN induction in HCV infection prior to
MAVS cleavage by the HCV NS3/4A.
PKR positively controls HCV yields through the inhibition
of the IFN induction pathway
We next examined whether there was a correlation between the
control of IFN induction by PKR, and HCV yields. Huh7.25/
CD81 cells were transfected with control siRNA or siRNA
directed against PKR as in Figure 7, and infected with JFH1, in
conditions where the IFN induction pathway was either active
after transfection with TRIM25, or not (Figure 8). The virus yields
were measured by RT-qPCR at different times post-infection.
First, ectopic expression of TRIM25 triggered a significant
inhibition of virus yields at 24 hrs post-infection (40%; Figure 8),
as expected from its ability to restore IFN induction in Huh7.25/
CD81 cells as shown in previous figures. Inhibition of virus yields
Figure 6. HCV triggers a transient inhibition of protein translation. Huh7.25.CD81 cells were transfected with 400 ng of CAT-IRES
HCV-LUC (A
and B) or 50 ng of CAT-IRES
EMCV-LUC (C and D), together with the pRL-TK-RLUC plasmid (40 ng) and the HA-TRIM25 expressing plasmid (100 ng).
24 hrs post-transfection, cells were infected with JFH1 at an m.o.i of 0.2. A and C: At the indicated times, total cellular RNA was extracted and F-luc
and GAPDH RNA were quantified by qRT-PCR. The graphs represent the number of copies of the IRES
HCV-luc (A) or of the IRES
EMCV-luc (C) RNA
normalized to the number of copies of GAPDH RNA. Error bars represent the mean 6 S.D. for triplicates. B and D: At the indicated times, cell lysates
were prepared and the IRES
HCV-luc or IRES
EMCV-luc activity was analysed by a reporter assay. For normalization, the levels of firefly luciferase activity
were divided in each case by the ratio R-luc RNA/GAPDH RNA that was calculated after measurement of the R-luc RNA by RTqPCR using the total
cellular RNA extracted for A and C. Error bars represent the mean 6 S.D. for triplicates.
doi:10.1371/journal.pone.0010575.g006
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Figure 8), in agreement with the block on IFN induction
downstream of TRIM25 imposed by the NS3/4A-mediated
cleavage of MAVS. Depletion of PKR from Huh7.25/CD81 cells
also triggered inhibition of virus yields. Interestingly, whereas this
inhibition was limited in the absence of TRIM25 (13% and 9%
inhibition at 24 and 48 hrs post-infection, respectively), it was
more pronounced when the cells were expressing TRIM25, with a
28% and 31% further increase in inhibition after 24 and 48 hrs of
infection, respectively (Figure 8). Altogether, the combined effect
of TRIM25 expression and PKR depletion resulted in 58% of
inhibition of HCV virus yields at 24 hrs and 56% at 48 hrs post-
infection. These data demonstrate that HCV infection is
particularly sensitive to the IFN induction pathway, and that the
efficiency of infection benefits from an inhibition of this pathway at
the translational level by PKR.
Pharmacological inhibitors of PKR increase IFN induction
and inhibit HCV infection
Although best known for its antiviral proprieties, PKR is now
also recognized for its negative effect on neurodegenerative
disorders such as Huntington’s, Parkinson’s and Alzheimer’s
diseases [16]. For these reasons, pharmacological inhibitors of
PKR have been developed. Here, we have used two PKR
inhibitors, the oxindole-imidazole C16 compound [17] and the
cell penetrating PRI peptide, that corresponds to one PKR motif
(DRBM) involved in binding to its activators. This latter
compound represents a more specific PKR inhibitor than C16
[18]. We examined the effects of these inhibitors on IFN induction
and HCV replication during infection of Huh7.25/CD81 cells
with JFH1 (Figure 9). The cells were transfected with TRIM25 as
described in Figure 7, and incubated with either C16 or PRI after
11 hrs of infection. The results clearly show that both PKR
inhibitors increased IFNb promoter induction (Figure 9A), as well
as restoring general level of protein expression (Figure S4). This
increase was more pronounced at 15–18 hrs post-infection
(Figure 9A). This highlights the importance of PKR activation
during this time-frame to control IFN induction. Next, the effect of
the PKR inhibitors on HCV replication was assayed. Huh7.25/
CD81 cells were transfected with TRIM25, or not, to have a non-
functional or functional RIG-I/MAVS pathway. Similarly to the
experiment shown in Figure 8, PKR inhibitors were able to inhibit
HCV yields only in conditions where the RIG-I/MAVS pathway
was activated (Figure 9B).
Figure 7. Depletion of PKR increases IFN induction in HCV-infected cells. Huh7.25.CD81 cells were first transfected with 25 nM of siRNA
directed against PKR or with 25 nM of control siRNA and then transfected 24 hrs later with the pGL2-IFNb-FLUC/pRL-TK-RLUC reporter plasmids and
the TRIM25 expressing plasmid. 24 hrs post-transfection the cells were infected with JFH1 at an m.o.i. of 0.2. A: At the indicated times, one set of cells
was treated for RNA extraction and the other for reporter assay as described in the legend to Figure 3. IFN expression was expressed as fold-induction
over control cells that were simply transfected with pGL2-IFNb-FLUC/pRL-TK-RLUC and either control siRNA or siPKR. The graph represents the levels
of firefly luciferase activity normalized to the ratio R-luc RNA/GAPDH RNA. Error bars represent the mean 6 S.D. for triplicates. In addition, cell lysates
were pooled and analysed for the presence of NS3 as a marker of HCV infection. B: Huh7.25.CD81 cells were treated as in A, except for transfection
with the reporter plasmids, to control the efficiency of PKR silencing. At the indicated times post-infection, cell extracts (1.7 mg) were incubated with
normal mouse IgG or Mab 71/10 anti-PKR. The immunoprecipitated complexes were run on SDS-12.5% PAGE gels and blotted using Mab 71/10 (PKR).
doi:10.1371/journal.pone.0010575.g007
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Here we report the use of HCV permissive Huh7.25.CD81 cells
to analyse the effect of HCV on the RIG-I/MAVS-mediated IFN
induction pathway during the early hours after infection, before
the HCV NS3/4A protease can cleave MAVS and abrogate this
pathway. We first observed that the IFN induction pathway was
deficient in these cells, but that it could be conveniently restored
upon ectopic expression of the E3 ubiquitin ligase TRIM25. This
protein has been shown to bind the threonine 55 residue of RIG-I
through its C terminal SPRY domain, and uses the E3 ligase
activity present in its N terminal RING domain to promote a
Lys63-type ubiquitination of RIG-I in its CARD domain at lysine
172. This modification is important if RIG-I is to engage in a
correct interaction with its downstream adapter MAVS [3]. The
nature of the TRIM25 defect in Huh7.25.CD81 cells and the
relation to activation of RIG-I is now under characterization. It is
interesting to note here that this defect emphasizes the importance
of the RIG-I/TRIM25 pathway in the control of HCV expression
since both Huh7.25.CD81 and Huh7.5 cells, which were
originally selected for their ability to replicate HCV subgenomic
replicons, present a defect in this pathway at the level of RIG-I for
Huh7.5 cells and of TRIM25 for Huh7.25.CD81 cells. Impor-
tantly, Huh7.25.CD81 cells can be considered as a more
physiological model than Huh7.5 cells to study the interaction
between the IFN induction pathway and HCV infection, since
Huh7.5 cells have a point mutation at the threonine 55 residue of
RIG-I [5] and therefore require ectopic expression of RIG-I to
restore their IFN induction pathway. In contrast, ectopic
expression of TRIM25 restores the IFN induction pathway
downstream of RIG-I and therefore does not perturb the initial
interaction between RIG-I and the incoming HCV dsRNA
structures.
Using Huh7.25.CD81 cells that ectopically express TRIM25,
we observed that HCV triggers IFNb induction as early as 6 hrs
after infection, demonstrating that the entry of the virus into the
cell rapidly generates enough viral structured RNAs to activate
RIG-I. NS3/4A expression was detected around 18 hrs post-
infection, and MAVS cleavage after 24 hrs post-infection. We thus
expected to observe an increase in IFNb induction at least until
18 hrs after infection. This was indeed found to be the case when
we analysed IFNb induction at the RNA level. However, when we
used a luciferase reporter gene placed under the IFNb promoter as
a surrogate marker for production of the IFNb protein, it was
intriguing to observe an arrest of IFN induction as rapidly as
12 hrs after infection, followed by a considerable decline in its
expression afterwards. These results indicated a new control of
IFN induction at the translational level during HCV infection in
addition to –and earlier than- the NS3/4A-mediated MAVS
cleavage. We have demonstrated that this inhibition is the result of
a strong activation of the protein kinase dsRNA-dependent kinase
PKR at 12 and 15 hrs after HCV infection and of the concomitant
phosphorylation of its substrate eIF2a.
Since this manuscript was submitted, work performed by
U.Garaigorta & F. Chisari showed that HCV also activates
PKR and eIF2a phosphorylation to negatively control the antiviral
action of IFN[19]. Both their and our data concur to point out that
HCV diverts PKR away from its known antiviral role to use it to
attenuate both the IFN-mediated antiviral response [19] and IFN
induction itself (our data). Importantly, both studies show that
PKR silencing has no effect on HCV production, unless cells are
Figure 8. PKR positively controls HCV yield through inhibition of the IFN induction pathway. Huh7.25.CD81 cells were first transfected
with 25 nM of siRNA directed against PKR or 25 nM of control siRNA and then transfected 24 hrs later with either empty vector or the TRIM25
expressing plasmid. 24 hrs post-transfection, the cells were infected with JFH1 at an m.o.i. of 0.2. At the indicated times, cells were processed for RNA
extraction and HCV RNAs were quantified by qRT-PCR and normalized against RNA from GAPDH. Error bars represent the mean 6 S.D. for triplicates.
doi:10.1371/journal.pone.0010575.g008
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study) or are directly treated with IFN [19].
PKR is a 551 aa serine/threonine protein kinase with its
catalytic domain at the C-terminus and regulating domains at the
N-terminus. This N-terminus domain contains two tandem copies
of a 70-amino acid dsRNA binding motif or DRBM (positions 6–
79 and 96–169) that affiliate PKR to the large family of dsRNA
binding proteins, which includes TRBP, PACT, DICER, ADAR,
RNAse III and NFAR’s [20]. Binding of PKR to dsRNA induces
its dimerization and a change of its conformation that frees access
to its autophosphorylation site. Structural analysis has revealed
that PKR dimers are arranged back to back, which prevents trans-
phosphorylation of one monomer by the other and favours a
model of autophosphorylation in cis or through the action of a
PKR dimer on other PKR dimers or monomers [21]. Once
autophosphorylated on its threonine T446, PKR is stabilized as a
kinase and can phosphorylate its substrates, such as the a subunit
of the initiation factor eIF2. PKR is preferentially activated upon
binding to long stretches of dsRNA (.33 bp) [22] but was recently
shown also to be activated upon binding to RNA structures similar
to those that activate RIG-I, such as short imperfect 16 bp stem-
loop RNAs with 59 triphosphorylated ends. It is now proposed that
perfect dsRNAs can activate PKR with no need for a 59ppp,
whereas if they are to activate, dsRNA with minimal secondary
structures are dependent on 59ppp [23]. In addition, PKR activity
can be regulated positively and negatively through interaction with
the cellular proteins PACT and TRBP, two members of the
dsRNA binding protein family. This type of interaction, which is
independent of the presence of dsRNA, is complex. The TRBP/
PACT interaction can modulate the activation of PKR by PACT
and a cellular stress reverses it [24].
Our results point out the ability of HCV to trigger both
induction of IFN and activation of PKR in the early hours of
infection. The induction of IFN is initiated by the binding of RIG-
Figure 9. Pharmacological inhibitors of PKR increase IFN induction and inhibit HCV infection. A: Huh7.25.CD81 cells were first
transfected with the pGL2-IFNb-FLUC/pRL-TK-RLUC reporter plasmids and the TRIM25 expressing plasmid. 24 hrs post-transfection, the cells were
infected with JFH1 at an m.o.i of 0.2. At 11 hrs post-infection, cells were exposed to 200 mM of C16 or 30 mM of the PRI peptide as described in
Materials and Methods. At the indicated times, one set of cells was treated for RNA extraction and the other for reporter assay as described in the
legend to Figure 3. IFN expression was expressed as fold-induction over control cells that were simply transfected with pGL2-IFNb-FLUC/pRL-TK-
RLUC. The graph represents the level of firefly luciferase activity normalized to the ratio R-luc RNA/GAPDH RNA. Error bars represent the mean +/- S.D.
for triplicates. B: Huh7.25.CD81 cells were first transfected with the TRIM25 expressing plasmid or an empty plasmid. 24 hrs post-transfection, the
cells were infected with JFH1 at an m.o.i of 0.2. At 11 hrs post-infection, cells were exposed to 200 mM of C16 or 30 mM of the PRI peptide as
described in Materials and Methods. At the indicated times, cell lysates were processed for RNA extraction and HCV RNAs were quantified by qRT-PCR
and normalized against RNA from GAPDH. Error bars represent the mean +/- S.D. for duplicates.
doi:10.1371/journal.pone.0010575.g009
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and/or replicative RNA duplexes [5,25]. In vitro experiments
have shown that PKR can be activated upon binding to the HCV
IRES [26] but it is currently not known exactly how HCV
activates PKR in vivo. The use of antibodies directed against
phosphorylated PKR or against phosphorylated eIF2a allowed in
vivo activation of PKR to be demonstrated, either upon HCV
subgenomic replicon replication [27] or more recently after
electroporation of Huh7 cells with JFH1 RNA [28]. Surprisingly,
the latter study showed that silencing of PKR resulted in 10-fold
higher viral yields compared to our study (Figures 8 and 9) and
that of Garaigorta & Chisari [19], where no effect on viral yields
could be observed unless the IFN induction pathway is triggered
or IFN is added to the cells. Although it is difficult to compare
different experimental systems, the discrepancy observed may be
due to the different procedures used to express JFH1 in the cells:
electroporation of its RNA in Kang’study, compared to infection
with JFH1 viral stocks in our study and that of Garaigorta &
Chisari. Interestingly, the differences might indicate that the mode
and/or efficiency of interaction between the HCV structures
required to activate PKR are crucial to determine how the virus
will benefit or suffer from PKR action. PKR has also been shown
to be activated through an interaction between its N terminal
domain and the first 58 amino acids of HCV core protein [29].
Core is the first HCV protein to be processed upon translation of
the viral polyprotein and may interact with endogenous PKR soon
after its own apparition in the cytosol. The possibility evoked here
that core is involved in PKR activation requires further
investigation.
Our results show that the IFN induction pathway can be
stimulated during HCV infection up to 12 hrs post-infection,
followed by a decline concomitantly with activation of PKR and of
its substrate eIF2a. Importantly, depletion of the endogenous PKR
by silencing, or inhibition of its function through the use of
pharmacological inhibitors, prevents this decline. This indicates
that HCV infection triggers an inhibition of general protein
synthesis through PKR, whereas its own translation is not affected,
as shown by the appearance of the viral proteins and an increase
in expression of a reporter gene placed under the control of an
IRES
HCV. These data are in agreement with a recent study which
showed, using in vitro experiments, that PKR can inhibit both
cap-mediated and IRES
EMCV-mediated translation, but not
IRES
HCV-mediated translation [26]. Shimoike et al proposed that
HCV uses alternate initiation factors that allow a mechanism of
translation initiation distinct from other IRES and from the
cellular machinery of general translation that is not inhibited by
eIF2a phosphorylation. The resistance of IRES
HCV to control of
translation may be related to a positive effect in trans from the virus
through some of its structures, such as the polyadenylated 39 UTR
[30]. Alternatively, translation from the HCV IRES may occur in
autophagy-like structures, together with translation from the
incoming HCV RNA, where it may escape PKR action [31]. By
both escaping and down regulating host cap-dependent transla-
tion, HCV may gain a further selective advantage for its own
replication and propagation.
Interestingly, we found that the depletion of PKR from
Huh7.25.CD81 cells, or incubation with the PKR inhibitors
C16 and PRI, leads to inhibition of HCV replication, but only
under conditions where the IFN induction pathway has been
restored by the expression of TRIM25. Our results thus
demonstrate that, among all the cap-dependent proteins the
expression of which are sensitive to PKR, only the translation of
proteins resulting from the activation of the IFN induction
pathway represent a real constraint for HCV replication and
propagation. Early activation of PKR upon HCV infection (12–
15 hrs post-infection) allows this virus to limit the expression of
I F Na n dp r o - i n f l a m m a t o r yc y t o k i n e sa ss o o na sp o s s i b l e ,b e f o r e
enough NS3/4A is translated from the HCV IRES to block this
signaling pathway through MAVS cleavage (18 to 24 hrs post-
infection) (see model in Figure 10). Through detailed kinetic
experiments, we demonstrated that phosphorylation of PKR
and of its substrate eIF2a are restricted to a 3 hour-period
between 12 and 15 hrs post-infection. Accordingly, the PKR
inhibitors C16 and PRI efficiently restored IFN induction
during this time. The use of both PKR silencing and the
addition of pharmacological inhibitors of PKR demonstrates the
importance of PKR in the control of IFN induction early after
infection with HCV. These results highlight that the 3-hour
period between 12 and 15 hrs post-infection is crucial for HCV
to activate PKR to restrain IFN expression, once it has launched
the IFN induction pathway through interaction of its replicative
dsRNA forms with RIG-I. Its ability to activate PKR at the
same time allows this induction to be moderated at the level of
the translation of this cytokine before sufficient NS3/4A
accumulates and abrogates IFN induction at the transcriptional
level through MAVS cleavage.
It was intriguing to observe that PKR and eIF2a phosphory-
lation decrease at 15 hrs post-infection with HCV, to reappear
progressively and increase from 24 hrs post-infection until the
72 hr end-point of the experiment (Figures 4 and 5). The reason
for this remains to be investigated and may indicate that PKR
could be sensitive to the action of phosphatase(s) at certain time
points of the infection.
PKR is well-recognized as an important effector of the antiviral
response through its ability to arrest protein synthesis and its
importance is highlighted by the number of viral and cellular
products that are able to abrogate or modulate its action [13,32].
In the case of HCV, some viral proteins such as NS5A and a
cytosolic soluble form of E2 were reported to interact with PKR,
and were proposed to be viral inhibitors of the antiviral action of
PKR [33,34,35].
Here, we show another aspect of the interaction of HCV with
PKR, that reveals how HCV uses the ability of PKR to inhibit
cellular cap-dependent translation, while avoiding its effect
through its own translation driven by the HCV IRES. PKR
silencing or PKR inhibitors have less effect on HCV production
when the RIG-I/MAVS pathway is non-operative. This demon-
strates that it is only IFN (and presumably also the pro-
inflammatory cytokines resulting from the activation of the RIG-
I/MAVS pathway) that represents a threat for viral propagation.
The situation we describe here might correspond to primo-
infection during the natural course of HCV infection in an IFN-
free environment, allowing unabated propagation of the virus due
to very limited production of IFN. In established chronic
infections, whatever IFN has been produced can then trigger
induction of a large number of ISGs (IFN-stimulated genes), such
as RIG-I and TRIM25, which can sustain the IFN induction
pathway, and ISG56 or viperin, which are involved in the
inhibition of HCV translation and replication [36,37]. Although
PKR is also recognized in several viral infections for its antiviral
proprieties, it may be more suitable to control its action in the case
of HCV infection. Therefore, we propose that a carefully-
controlled use of PKR inhibitors, in conjunction with IFN/
ribavirin, would be beneficial for the treatment of chronically
HCV-infected patients, since it would lead to a boost in the
induction of innate immunity and a sustained inhibition of the
viral propagation.
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Cell culture
Huh7 and Huh7.5 cells were cultured in Dulbecco’s modified
Eagle’s Medium (DMEM; Sigma) supplemented with 10%
heat-inactivated fetal bovine serum, 1% nonessential amino
acids (Gibco BRL) and 1% penicillin/streptomycin (Invitro-
gen). Huh7.25/CD81 cells were cultured in the same
medium supplemented with 0.4 mg/ml geneticin (G418; PAA
Laboratories).
Viruses
Sendai virus stocks were grown in the allantoic cavities of 9-day-
old embryonated chicken eggs that were provided by D. Garcin, as
described [38]. For the preparation of HCV stocks, Huh7.5 cells
plated in 150 cm
2 flasks were inoculated with JFH1 at an m.o.i of
0.05, in serum-free DMEM. After 2 hrs at 37uC, the medium was
removed and replaced with complete medium. Three days after
infection, the cells were dissociated by trypsin treatment, and
replated in 3 or 4 150 cm
2 flasks. After 3 more days, the JFH1-
containing cell supernatants were collected, centrifuged at
1200 rpm for 10 min at 4uC, cleared of debris by passing through
0.45-mm-pore-size filters, and stored at 280uC. The cells were
trypsinated once again, passaged in 1 or 2 150 cm
2 flasks and viral
supernatants were collected again after 24 hrs and stored at
280uC. For titration, Huh7.5 cells (10
5 cells/well in a 24-well
plate) were incubated in the presence of serial dilutions of the viral
preparations. After three days, cells were washed with PBS, fixed
for 20 min with 4% paraformaldehyde-PBS (PFA; Electron
Microscopy Sciences), permeabilized by incubation for 1 hour
with PBS that contained 1% gelatin (Sigma) and 0.1% Tween-20
(Sigma), and incubated for 1 hour with 150 ml of PBS-gelatin that
contained serum from a patient chronically infected with HCV
(genotype 1b) at a 1/500 dilution. Cells were washed and
incubated with peroxidase-conjugated anti-human antibody (1/
2500 dilution; Dako), and the presence of the virus was detected
using the Vector NovaRED substrate kit for peroxydase
(VECTOR). Infectious foci were counted under a microscope
and the titer was calculated as focus forming units per ml. Titers of
6.10
4 FFU/mL were obtained on a routine basis.
Plasmids, siRNAs and antibodies
The pcDNA3 expressing 59HA tagged-TRIM25 was provided
by D. Garcin. The CAT-IRES
HCV-LUC and CAT-IRES
EMCV-
LUC constructs have been described [39]. The IFNb-firefly
luciferase (pGL2-IFNb) and pEF-BOS FLAG-RIG-I plasmids
were described previously [40]. The pcDNA3.1 cMyc-MAVS has
been described [41]. Control (scrambled) siRNA and siRNA to
PKR (GCAGGGAGUAGUACUUAAAUAUU) were synthesized
by Dharmacon Research, Inc. (Lafayette, CO). The siRNAs (final
concentration 25 nM) were transfected for 24 h using FuGENE
HD (ROCHE) before the transfection with other plasmids, or
infection. Normal mouse IgG were from Santa Cruz Biotechnol-
ogy. Monoclonal anti-PKR 71/10 antibody was obtained from
A.Hovanessian [42]. Anti-actin antibody was from Sigma. Rabbit
polyclonal antibodies were used to detect eIF-2a phosphorylated
at Serine 51 (Cell Signalling Technology), PKR phosphorylated at
Thr451 (AbCAM), and MAVS (Alexis Biochemical Inc.). Mouse
monoclonal antibodies were used to detect HCV NS3 and the HA
tag (Chemicon and 12CA5; Roche, respectively).
Figure 10. Model of regulation of IFN b induction at the very early steps of HCV infection. Left panel: 6–12 hrs after infection. After cell
entry, the HCV genomic RNA is liberated, and thus dsRNA structures are accessible in the cytosol and can associate with the RIG-I RNA helicase. This
triggers activation of RIG-I followed by its ubiquitination by the E3-ligase TRIM25, and interaction with the mitochondria-bound MAVS adapter. MAVS,
in turn, activates downstream signalling kinases leading to IRF3 phosphorylation and induction of IFNb. Detection of IFNb expression starts at 6 hrs
p.i. and increases until 12 hrs post-infection. Induced IFNb mRNA moves to the cytosol and is translated into IFNb protein through the cap-
dependent process of cellular translation. Middle panel: 12–18 hrs after infection. HCV infection triggers the activation of PKR through a still
unknown mechanism (either through its dsRNA or through a viral protein, such as core, or through activation of a cellular protein, such as PACT).
Once activated, PKR phosphorylates its substrate, the a subunit of the eIF2 initiation complex and arrests the cap-dependent protein synthesis. As a
result, translation of IFNb protein stops. Right panel: 18–24 hrs after infection. HCV proteins have been translated through a cap-independent
mechanism and begin to accumulate in the cytosol. The viral NS3 protease cleaves MAVS at residue 508. This results in complete inactivation of
MAVS, arrest in the recruitment of its downstream kinases and arrest of IFN induction. Note that after 15 hrs, PKR is no longer phosphorylated, hence
no longer activated. The mechanism of this regulation is not yet known. RIG-I: Retinoic acid Inducible Gene 1; CARD: Caspase Recognition Domain;
RD: Repressor Domain, Ub:Ubiquitin; MAVS: Mitochondria Adaptor Virus Signalling; TM: Transmembrane domain; PKR: Protein Kinase RNA-
dependent; IRF3: Interferon Regulatory Factor 3; eIF2a: a subunit of eukaryotic Initiation Factor; AAA: polyadenylated tail. P: phosphate group.
doi:10.1371/journal.pone.0010575.g010
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Huh7, Huh7.5 and Huh7.25.CD81 cells (80,000 cells/well; 24-
well plates) were transfected with 40 ng of pRL-TK Renilla-
luciferase (R-luc) reporter (Promega); 150 ng of pGL2-IFNb-
Firefly luciferase (F-luc) reporter, 400 ng of CAT-IRES
HCV-Luc
or 50 ng of CAT-IRES
EMCV-Luc reporter; and pEF-BOS FLAG-
RIG-I, pcDNA3 HA-TRIM25 or pcDNA3 cMyc-MAVS as
indicated. Transfections were performed in the presence of the
FuGENE HD reagent (ROCHE) according to the manufacturer’s
instructions. Cells were then incubated for 24 hrs before being
mock-treated or infected with either SeV or JFH1. At different
times post-infection, cells were processed for a reporter assay. For
most of our experiments concerning activation of PKR and
inhibition of general translation, normalization of the data was
performed using Renilla luciferase RNA rather than its activity.
All assays were performed in triplicate in two different sets of cells,
plated, transfected and infected in the same conditions. For the
reporter assay, the medium was removed and 100 ml of lysis buffer
(Passive lysis buffer; Promega) was added to each well, and
incubation was at room temperature for 15 minutes with gentle
agitation. Luciferase activity was measured using the dual-
luciferase reporter assay system, according to the manufacturer’s
instructions (Promega). RTqPCR analysis was performed on
Renilla luciferase RNA and GAPDH RNA after extraction of total
cellular RNA. The measured amount of Renilla luciferase RNA
was normalized to the amount of GAPDH RNA and this ratio was
used to normalize the Firefly luciferase activity.
To estimate the effficacy of transfection, Huh7.25.CD81 cells
(80,000 cells/well; 24-well plates) were separately transfected with
1 mg of pcDNA3 Lac-Z in presence of FuGENE HD reagent.
24 hrs post-transfection, cells were fixed in 4% PFA and incubated
for a few minutes with 200 ml of X-Gal stain (PBS, pH 7.2; 2 mM
MgCl2; 4 mM potassium ferricyanide; 4 mM potassium ferrocy-
anide and 1 mg of X-Gal (Sigma) previously dissolved in DMSO).
X-Gal-stained cells were counted in different sections of the plate
and the cell density was determined as a function of the measured
area of the section examined. Quantification from three fields
taken at random allowed an estimation of 45% of the efficacy of
transfection.
Real-time RT-PCR Analysis
Total cellular RNA was extracted using the TRIZOL reagent,
according to the manufacturer’s instructions (Invitrogen). HCV
RNA was quantified by one-step qRT-PCR. Reverse-transcrip-
tion, amplification and real-time detection of PCR products were
performed with 5 ml total RNA samples, using the SuperScript III
Platinum one-step qRT-PCR kit (Invitrogen) and an AbiPrism
7700 machine. The sequence of the primers used for HCV RNA
amplification are: 59-TGCGGAACCGGTGAGTACA-39 and 59-
CGGGTTGATCCAAGAAAGGA-39, together with the internal
probe 59FAM- CGGAATTGCCAGGACGACCGG-39TAMRA.
IFN-b RNA, Renilla luciferase RNA and Firefly luciferase RNA
were quantified by a two-step qRT-PCR assay. The reverse
transcription step was performed on 1 mg of total RNA.
Quantitative PCR was performed using an AbiPrism 7700
machine, with a SYBR GREEN PCR Master Mix (Applied
BioSystemes). IFN-b was amplified using the primers: 59-
TGCATTACCTGAAGGCCAAG-39 and 59-AAGCAATTGT-
CCAGTCCCA-39; Renilla luciferase was amplified using the
primers: 59-ATCATCCCTGATCTGATCGG-39 and 59-GGAG-
TAGTGAAAGGCCAGAC-39 and Firefly luciferase with the
primers: 59-GAAGAGATACGCCCTGGTTCCT-39 and 59-
TGTCCACCTCGATATGTGCATC-39. Standard curves were
established as described [40] using 10-fold serial dilutions of
plasmids containing IFN-b, R-luc or F-luc amplicons. The results
were normalized to the amount of GAPDH RNA using the
GAPDH control kit from EuroGentec.
Immunoprecipitation and Immunoblot analysis
Cells were washed once with phosphate-buffered saline and
scraped into lysis buffer (50 mM TRIS-HCl, pH 7.5, 140 mM
NaCl, 5% glycerol, 1% CHAPS) that contained cocktails of
phosphatase and protease inhibitors (Complete, Roche Applied
Science). The protein concentration was determined by the
Bradford method. For immunoprecipitation, lysates were incubat-
ed at 4uC overnight with monoclonal anti-PKR 71–10 antibody or
anti-eIF2a antibody, and then in the presence of A/G-agarose
beads (Santa Cruz Biotechnology) for 60 minutes. The beads were
washed three times, and the precipitated proteins were extracted
at 95uC using SDS-PAGE sample buffer. Protein electrophoresis
was performed on standard SDS-PAGE or NuPAGE gels
(Invitrogen). Proteins were respectively transferred onto polyviny-
lidene difluoride membranes (BioRad) or nitrocellulose mem-
branes (Biorad), and probed with specific antibodies. Immunoblots
were revealed using either the ECL Plus Western Blotting
Detection System (Amersham Biosciences) or chemiluminescence.
In the latter case, nitrocellulose membranes were blocked in
Odyssey Blocking Buffer (Rockland) for one hour and incubated
with primary antibodies in Odyssey Blocking Buffer with gentle
shaking. They were then incubated for 35 mn in the presence of
appropriate secondary antibodies labelled with IRDye 800
(Rockland Immunochemicals), with gentle shaking and protection
from light. Fluorescent immunoblot images were acquired and
quantified by using an Odyssey scanner and the Odyssey 1.2
software (Li-Cor Biosciences).
Chemical treatments
The cell-permeable peptide containing the DRBM of double-
stranded RNA-dependent protein kinase (PRI peptide [18];
Sanofi-Aventis, Vitry sur Seine, France; dissolved in water), and
the C16 compound ([17]; Calbiochem; solubilized in DMSO),
were provided by Jacques Hugon. Huh7.25.CD81 cells were
infected by JFH1 for 11 hrs, washed once with phosphate buffered
saline and then exposed to serum-free DMEM containing either
200 mM of C16 or 30 mM of PRI peptide. In the latter case, the
cells received fresh aliquotes of the PRI peptide (30 mM final
concentration) every hour until the end of treatment to maximise
the effect of the peptide. At different times after infection, cells
were lysed and analysed by reporter assay or real-time RT-PCR as
decribed above.
Supporting Information
Figure S1 Specific inhibition of TK-Renilla luciferase activity
12 hrs post-infection with HCV. The graphs represent the R-luc
activity normalized to R-luc RNA in the cell extracts correspond-
ing to the experiment described in Figure 3, in which
Huh7.25.CD81 cells (A) or Huh7.5 cells (B) have been infected
with either SeV (top) or HCV (bottom). Error bars represent the
mean 6 S.D. for triplicates.
Found at: doi:10.1371/journal.pone.0010575.s001 (1.19 MB TIF)
Figure S2 Inhibition of TK-Renilla luciferase activity 12 hrs
post-infection with HCV in the presence of an IRES either from
HCV or from EMCV. The graphs represent R-luc activity
normalized to R-luc RNA in the cell extracts corresponding to the
experiment described in Figure 6, in which Huh7.25.CD81 cells
have been transfected with 400 ng of CAT-IRESHCV-LUC (A)
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TK-RLUC plasmid (40 ng) and the HA-TRIM25 expressing
plasmid (100 ng). Error bars represent the mean 6 S.D. for
triplicates.
Found at: doi:10.1371/journal.pone.0010575.s002 (0.15 MB TIF)
Figure S3 Silencing of endogenous PKR abrogates HCV-
mediated inhibition of TK-Renilla luciferase activity. The graphs
represent R-luc activity normalized to R-luc RNA in cell extracts
corresponding to the experiment described in Figure 7, where
Huh7.25.CD81 cells were first transfected with 25 nM of siRNA
directed against PKR or with 25 nM of control siRNA and then
transfected 24 hrs later with the pGL2-IFNb-FLUC/pRL-TK-
RLUC reporter plasmids and the TRIM25 expressing plasmid.
24 hrs post-transfection, the cells were infected with JFH1 at an
m.o.i. of 0.2. Error bars represent the mean 6 S.D. for triplicates.
Found at: doi:10.1371/journal.pone.0010575.s003 (0.71 MB TIF)
Figure S4 Pharmacological inhibitors of PKR abrogate the
HCV-mediated inhibition of TK-Renilla luciferase activity. The
graphs represent R-luc activity normalized to R-luc RNA in cell
extracts corresponding to the experiment described in Figure 9A,
in which Huh7.25.CD81 cells were first transfected with the
pGL2-IFNb-FLUC/pRL-TK-RLUC reporter plasmids and the
TRIM25 expressing plasmid. 24 hrs post-transfection, the cells
were infected with JFH1 at an m.o.i of 0.2. At 11 hrs post-
infection, cells were exposed to 200 mM of C16 or 30 mM of the
PRI peptide. Error bars represent the mean 6 S.D. for triplicates.
Found at: doi:10.1371/journal.pone.0010575.s004 (0.99 MB TIF)
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